Rheumatology (Oxford, England), 2014-02, Vol.53 (2), p.284-284
2014
Details
- Autor(en) / Beteiligte
- Titel
- Cerebral toxoplasmosis following adalimumab treatment in rheumatoid arthritis
- Ist Teil von
- Rheumatology (Oxford, England), 2014-02, Vol.53 (2), p.284-284
- Ort / Verlag
- England
- Erscheinungsjahr
- 2014
- Link zum Volltext
- Quelle
- Oxford Journals 2020 Medicine
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1462-0324eISSN: 1462-0332DOI: 10.1093/rheumatology/ket364Titel-ID: cdi_proquest_miscellaneous_1496893951
- Format
- –
- Schlagworte
- Adalimumab, Aged, Antibodies, Monoclonal, Humanized - adverse effects, Antibodies, Monoclonal, Humanized - therapeutic use, Antirheumatic Agents - adverse effects, Antirheumatic Agents - therapeutic use, Arthritis, Rheumatoid - drug therapy, Biopsy, Brain - parasitology, Brain - pathology, Humans, Male, Risk Factors, Toxoplasma - isolation & purification, Toxoplasmosis, Cerebral - chemically induced, Toxoplasmosis, Cerebral - diagnosis, Toxoplasmosis, Cerebral - etiology, Tumor Necrosis Factor-alpha - antagonists & inhibitors